Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deacon

Showing results (71-80 of 2,132) with videos related to

Pageof 214
Sort By:
Frontiers in Endocrinology|March 5, 2019
Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 DiabetesCarolyn F Deacon
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 19, 2005
Circulation and degradation of GIP and GLP-1C F Deacon
Current Opinion in Investigational Drugs (London, England : 2000)|May 19, 2005
MK-431 (Merck)Carolyn F Deacon
British Medical Journal|January 14, 1978
Beta-blocking drugs in diabetesS P Deacon
Peptides|November 11, 2019
Metabolism of GIP and the contribution of GIP to the glucose-lowering properties of DPP-4 inhibitorsCarolyn F Deacon
Annals of Clinical Biochemistry|July 1, 1988
Performance of screening tests for porphyriaA C Deacon
The Journal of the Society of Occupational Medicine|January 1, 1991
Screening for coronary risk factors in occupational health practiceS P Deacon
British Medical Journal|May 28, 1977
Pituitary-dependent Cushing's diseaseS P Deacon
Nature Reviews. Endocrinology|September 15, 2020
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitusCarolyn F Deacon
British Medical Journal|November 20, 1971
Reversible sterilization in the femaleA L Deacon
Pageof 214

Showing results (71-80 of 2,132) with videos related to

Sort By:
Pageof 214
Frontiers in Endocrinology|March 5, 2019
Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 DiabetesCarolyn F Deacon
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 19, 2005
Circulation and degradation of GIP and GLP-1C F Deacon
Current Opinion in Investigational Drugs (London, England : 2000)|May 19, 2005
MK-431 (Merck)Carolyn F Deacon
British Medical Journal|January 14, 1978
Beta-blocking drugs in diabetesS P Deacon
Peptides|November 11, 2019
Metabolism of GIP and the contribution of GIP to the glucose-lowering properties of DPP-4 inhibitorsCarolyn F Deacon
Annals of Clinical Biochemistry|July 1, 1988
Performance of screening tests for porphyriaA C Deacon
The Journal of the Society of Occupational Medicine|January 1, 1991
Screening for coronary risk factors in occupational health practiceS P Deacon
British Medical Journal|May 28, 1977
Pituitary-dependent Cushing's diseaseS P Deacon
Nature Reviews. Endocrinology|September 15, 2020
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitusCarolyn F Deacon
British Medical Journal|November 20, 1971
Reversible sterilization in the femaleA L Deacon
Pageof 214